Internal Medicine, Endocrinology, Diabetes, & Metabolism · Tampa, FL
NPI
1427187319
Since 2007
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
3
Medicare group memberships
Hospitals
5
Hospital affiliations
4816 N Armenia Ave
Tampa, FL, 33603
Phone (813) 876-3636
Groups this clinician bills Medicare through
Medicare paid, 2024
$431K
6,710 services
Medicare patients, 2024
1,406
Average age 76
Drug cost, 2024
$1.6M
3,358 prescriptions
Company payments, 2025
$1,662
From 23 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Pedro I Troya was code 99232 (hospital e&m - subsequent), 1,779 times for 354 patients. In total Pedro I Troya billed 6,710 services in 19 codes, and Medicare paid $431K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-07-21.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 1,779 | 354 | $61.29 | $109K |
| 99308 SNF E&M | Facility | 1,446 | 322 | $57.56 | $83K |
| 99458 E&M - Miscellaneous | Office | 588 | 67 | $30.09 | $18K |
| 99214 Office E&M - Established | Office | 572 | 288 | $89.51 | $51K |
| 99457 E&M - Miscellaneous | Office | 571 | 67 | $37.11 | $21K |
| 99223 Hospital E&M - Initial | Facility | 395 | 346 | $134.46 | $53K |
| 99454 E&M - Miscellaneous | Office | 379 | 46 | $34.77 | $13K |
| 99213 Office E&M - Established | Office | 318 | 235 | $61.42 | $20K |
| 99306 SNF E&M | Facility | 279 | 279 | $141.10 | $39K |
| 99231 Hospital E&M - Subsequent | Facility | 174 | 50 | $38.87 | $6,763 |
| 95251 Test - Miscellaneous | Office | 66 | 44 | $24.37 | $1,609 |
| 76536 Ultrasound - Nonspecific | Office | 43 | 41 | $72.85 | $3,133 |
| 99204 Office E&M - New | Office | 40 | 40 | $124.23 | $4,969 |
| 99205 Office E&M - New | Office | 35 | 35 | $160.81 | $5,628 |
By year: 2022 $260K for 3,399 services; 2023 $435K for 6,544 services; 2024 $431K for 6,710 services.
Medicare prescription drug claims, 2024
In 2024, the drug Pedro I Troya prescribed most often to Medicare patients was Levothyroxine Sodium, with 484 prescriptions and refills. In total Pedro I Troya wrote 3,358 Medicare prescriptions that cost $1.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 484 | 1,311 | 142 | $5,247 |
| Ozempic Semaglutide | 234 | 432 | 66 | $416K |
| Metformin Hcl Generic | 193 | 535 | 67 | $8,159 |
| Synthroid Levothyroxine Sodium | 153 | 402 | 44 | $17K |
| Jardiance Empagliflozin | 128 | 340 | 42 | $160K |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 102 | 269 | 38 | $21K |
| Metformin Hcl Er Metformin Hcl | 98 | 286 | 32 | $1,326 |
| Methimazole Generic | 97 | 231 | 26 | $927 |
| Humalog Kwikpen U-100 Insulin Lispro | 91 | 200 | 31 | $26K |
| Tresiba Flextouch U-100 Insulin Degludec | 72 | 185 | 23 | $56K |
| Glimepiride Generic | 71 | 214 | 23 | $824 |
| Mounjaro Tirzepatide | 68 | 104 | 19 | $108K |
| Pioglitazone Hcl Generic | 53 | 160 | 20 | $778 |
| Novolog Flexpen Insulin Aspart | 51 | 132 | 19 | $17K |
| Farxiga Dapagliflozin Propanediol | 49 | 114 | 17 | $63K |
Brand drugs: 1,902 claims; generic drugs: 1,221 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Pedro I Troya $1,662 ($1,662 in general payments such as food, travel and fees) from 23 companies. The largest payer was Novo Nordisk Inc with $410.
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc NVO | 24 | $410 |
| Beta Bionics, Inc. BBNX | 5 | $208 |
| Recordati_rare_diseases_inc. | 3 | $87.2 |
| Dexcom, Inc. DXCM | 4 | $85.11 |
| Madrigal Pharmaceuticals MDGL | 3 | $84.65 |
| Amgen Inc. AMGN | 4 | $77.91 |
| Avvisto Therapeutics, LLC | 4 | $73.49 |
| Corcept Therapeutics CORT | 3 | $71.32 |
| Lilly USA, LLC LLY | 3 | $66.64 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $66.32 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.